For chronic pain patients, though, the brain interprets even neutral sensations as pain and suffering. In effect, pain ...

A new therapy is showing promise for patients living with the autoimmune condition, rheumatoid arthritis. Dawn Steiner said ...

More than 18-million people worldwide are living with rheumatoid arthritis. It can be painful, but a new therapy is showing promise. Rheumatoid arthritis causes swelling, stiffness, and joint pain and ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.